Prokidney PROK
NASDAQ PROK
$1.85 -0.14 (-7.04%)
At close: Sep 9, 2026 · 4:00 PM EDT

Prokidney (PROK) Operating Leases (2021 - 2026)

Prokidney's (PROK) quarterly Operating Leases came in at $2.4 million in Q2 2026, down 31.89% year-over-year from $3.5 million in Q2 2025, and down 10.5% quarter-over-quarter from $2.7 million in Q1 2026.

Analysis

Prokidney (PROK) Operating Leases (2021 - 2026) Analysis & Trends

Prokidney (PROK) has reported Operating Leases for 6 consecutive years, with $2.4 million the latest figure, recorded in Q2 2026.

  • On a quarterly basis, Operating Leases fell 31.89% year-over-year to $2.4 million in Q2 2026; TTM through Jun 2026 was $2.4 million, a 31.89% decrease from a year earlier, with the FY2025 full-year figure at $3.0 million, up 19.99% from the prior year.
  • Operating Leases was $2.4 million for Q2 2026 at Prokidney, down from $2.7 million in the prior quarter.
  • Over five years, Operating Leases peaked at $5.6 million in Q2 2024 and troughed at $1.7 million in Q3 2022.
  • A 5-year average of $3.1 million and a median of $2.6 million in 2025 frame the typical range for Operating Leases.
  • Across the five-year window, Operating Leases jumped 154.72% in 2024 and slumped 48.3% in 2025, its largest moves.
  • Over 5 years, Operating Leases stood at $1.9 million in 2022, then jumped by 89.4% to $3.6 million in 2023, then tumbled by 31.55% to $2.5 million in 2024, then rose by 19.99% to $3.0 million in 2025, then retreated by 19.26% to $2.4 million in 2026.
  • The last three Operating Leases figures came in at $2.4 million (Q2 2026), $2.7 million (Q1 2026), and $3.0 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Krystal Biotech 10.27 Bn 9.43 Bn 112.79 Mn
2 CRISPR Therapeutics AG 5.17 Bn 5.17 Bn -
3 Iovance Biotherapeutics 3.79 Bn 3.49 Bn 55.72 Mn
4 Legend Biotech 3.68 Bn 2.71 Bn 251.50 Mn
5 uniQure 3.05 Bn 3.05 Bn 5.49 Mn
6 Beam Therapeutics 2.65 Bn 2.65 Bn -
7 Precigen 2.44 Bn 2.44 Bn 52.17 Mn
8 Sarepta Therapeutics 2.33 Bn 1.53 Bn 251.87 Mn
9 Vericel 1.99 Bn 1.83 Bn 56.40 Mn
10 Prokidney 346.07 Mn 346.07 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2.39 Mn
Mar 31, 2026 2.68 Mn
Dec 31, 2025 2.97 Mn
Sep 30, 2025 3.25 Mn
Jun 30, 2025 3.52 Mn
Mar 31, 2025 2.51 Mn
Dec 31, 2024 2.47 Mn
Sep 30, 2024 5.37 Mn
Jun 30, 2024 5.64 Mn
Mar 31, 2024 4.86 Mn
Dec 31, 2023 3.61 Mn
Sep 30, 2023 2.11 Mn
Jun 30, 2023 2.29 Mn
Mar 31, 2023 2.47 Mn
Dec 31, 2022 1.91 Mn
Sep 30, 2022 1.72 Mn
Dec 31, 2021 1.07 Mn